REMATIQ

Name: REMATIQ
Brand: REMATIQ

AI Native

You build what matters. We simplify what’s required.

Est 2023

LinkedIn 6K|Website|FTEs 19|HQ Berlin, Berlin, DE

MarketsQuality Assurance

Published Aug 26, 2026

01Common complaints

- If your procurement requires publicly available SOC 2 or ISO 27001 documentation before initiating vendor engagement: such certifications were not publicly documented in the vendor pages accessed for this report. - If you need abundant independent user reviews on platforms such as G2, TrustRadius, or Gartner Peer Insights to de-risk the purchase: REMATIQ has limited visibility on those platforms in accessible searches. - If your primary requirement is a mature, field-proven requirements management tool rather than an automation overlay: established RM/ALM vendors may be a lower-risk option for classic RM needs. - If you cannot fund or resource integration and data normalization work: achieving cross-system traceability typically requires investment in integration, artifact normalization, and ongoing governance.

Deal disqualifiers (poor fit)

Very small startups or teams with minimal regulatory burden or single-product simplicity.
Organizations that cannot accept AI-assisted workflows due to policy or validation constraints.
Teams that require extensive independent reviews and public certification documents before procurement.

Publicly acknowledged limitations / roadmap

No explicit public roadmap or known-issues page was found in the vendor sources used for this report.

Practical limitations to watch (inferred)

Validation and audit defensibility: AI-assisted compliance work needs strong provenance, documented review workflows, and controlled changes to meet regulatory expectations.
Data governance: graph-based traceability systems depend on consistent taxonomy, artifact identifiers, and change control processes.
Review throughput: human review effort may remain significant depending on the quality of AI outputs and the organization’s risk tolerance.

02Why they buy

Potential unique selling points (vendor-stated; require validation)

A traceability and compliance graph intended to link regulations, requirements, and evidentiary artifacts to address silo fragmentation.
Automation agents that execute configurable workflows with human review, designed for regulated use cases.

Where competitors may have an advantage

Established ALM/RM vendors have longer track records, broader integrations, and larger installed bases, which can reduce implementation risk.
Some competitors publish trust centers or certification information publicly; the vendor pages reviewed for this report did not provide the same level of public security documentation.

03Field reports

What’s available (and what’s missing)

Public, independent reviews of REMATIQ on mainstream B2B review platforms are scarce or not readily accessible at the time of this research: - Gartner Peer Insights: No clearly accessible REMATIQ product review page was identified in the search results used. - G2: No REMATIQ review listings were found in accessible search results. - TrustRadius: No REMATIQ product review listings were found in accessible search results. - Capterra: No REMATIQ listing was found in the searches performed. Implication: A balanced comparison based on independent platform reviews is not currently possible with high confidence from the usual sources.

Vendor-provided testimonial (vendor-curated)

The vendor site includes at least one homepage testimonial attributed to a named regulatory leader at a large medical company. This quote should be treated as vendor-curated marketing content and not as an independently verified case study with methodology.

Community/social discussions (contextual relevance)

Searches did not identify prominent Reddit or Hacker News threads specifically about REMATIQ. Broader community discussions about using AI in medical device regulatory work note risks such as AI output missing device-specific context and clause-level obligations. These community observations are relevant context for evaluating AI-assisted compliance tools but are not direct evaluations of REMATIQ.

Public case studies

No detailed REMATIQ case study pages were located in the accessible vendor site research performed for this report.

Vendor-claimed outcomes (not independently verified)

The vendor markets outcomes such as faster time to market through automated submission documentation generation; vendor-stated efficiency improvements; and improved traceability via linkage across systems. These outcomes are plausible in principle, particularly when manual reconciliation is being replaced, but the vendor does not publish methodology or independent verification. Prospective buyers should request the following from the vendor to evaluate claimed outcomes: - before and after process maps, - measured time savings by workflow type, - evidence of reduced submission deficiencies or defect rates, - documentation explaining how percentage improvements were calculated.

04Best fit

Company sizes

Based on vendor positioning and the scale of integration problems described, the strongest fit is likely mid-market to enterprise organizations — typically organizations with hundreds to thousands of employees. This is directional and not vendor-verified.

Industries

Medical devices and adjacent life sciences product development organizations with significant regulatory and compliance obligations.

Roles/personas

Decision makers: heads or VPs of Regulatory Affairs, Quality, R&D Engineering leadership, and Digital Transformation.
End users: regulatory affairs specialists, design control owners, quality engineers, systems engineers, and document control personnel.

Qualification criteria (good fit)

Multiple disconnected systems (ALM/QMS/RIM and document repositories) with manual reconciliation tasks.
High audit burden with frequent internal or external audits and regulatory submissions.
Organizational willingness to invest in process standardization, integration, and governance.

05The pitch

What the product does (objective value proposition)

REMATIQ is an AI-assisted compliance and requirements automation platform targeted at regulated product development, with an emphasis on medical devices. The product aims to connect distributed compliance artifacts (requirements, processes, evidence, and documentation) and automate compliance workflows using configurable automation agents with human review. The vendor describes a central product construct as a traceability and compliance graph that links regulations → requirements → evidence, and that records versioning and logging of actions for auditability. Key capabilities described on the product site include: - AI agents and configurable workflows to automate compliance tasks, with human review of outputs. - Capture and connection of external data in multiple formats, including integrations to ALM/QMS/RIM systems. - A traceability and compliance graph for end-to-end linkage and impact analysis. - Controlled workflows with versioning, traceability, and logging of actions. - Feature themes: regulatory requirements library/SSOT, QMS compliance checks, design input verification, regulatory impact assessment, submission checks. Evidence: REMATIQ product page.

Target market and positioning

Primary vertical: medical devices and life sciences regulatory and product compliance.
Positioning: the vendor markets the product as an automation layer intended to operate across existing systems rather than as a monolithic replacement for ALM/QMS solutions.

Evidence: REMATIQ About page and homepage positioning.

Get a comprehensive analysis of REMATIQ including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →